Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05538351

A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
University of Hertfordshire · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute Kidney Injury (AKI) is the sudden and recent reduction in kidney function. This can be detected by measuring a rise in blood creatinine level or from a reduction in urine. Reasons for developing AKI, include dehydration, low blood pressure, medication and infection. When the kidneys stop working, there can be a build-up of toxins and fluid. It is extremely important to identify a patient's fluid status as too little can cause further damage to the kidneys and too much can be harmful. Assessment is varied and often inaccurate and there needs to be a standard approach to fluid assessment.

Detailed description

Acute Kidney Injury (AKI) is the sudden and recent reduction in kidney function. This can be detected by measuring a rise in blood creatinine level or from a reduction in urine. Reasons for developing AKI, include dehydration, low blood pressure, medication and infection. When the kidneys stop working, there can be a build-up of toxins and fluid. It is extremely important to identify a patient's fluid status as too little can cause further damage to the kidneys and too much can be harmful. Assessment is varied and often inaccurate and there needs to be a standard approach to fluid assessment. Aim: To develop an Enhanced Fluid Assessment Tool for patients with AKI. Workstream 1: Aim: To identify what methods are useful to assess fluid in a patient with AKI. The fluid assessment techniques that are useful and are used, bioimpedance and patient reported signs and symptoms. Workstream 2: Aim: To identify the best methods of determining fluid status in a patient with AKI The findings from Workstream 1 will be used to rank the most useful fluid assessment techniques. This will lead to the development of the enhanced fluid assessment tool. Workstream 3: Aim: To assess if the tool is practical and clinically useful in determining a patient's fluid status. The terminology and language will be reviewed and the tool will be used to assess patients and to determine the patients fluid status.

Conditions

Interventions

TypeNameDescription
DEVICEBody Composition Monitor (BCM)The hydration status of each participant from the clinical assessment and the patient reported signs and symptoms will be compared with the readings from bioimpedance (BCM machine).

Timeline

Start date
2022-09-09
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2022-09-13
Last updated
2025-12-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05538351. Inclusion in this directory is not an endorsement.

A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury (NCT05538351) · Clinical Trials Directory